1. Home
  2. MCB vs ATXS Comparison

MCB vs ATXS Comparison

Compare MCB & ATXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Metropolitan Bank Holding Corp.

MCB

Metropolitan Bank Holding Corp.

HOLD

Current Price

$91.73

Market Cap

906.2M

Sector

Finance

ML Signal

HOLD

Logo Astria Therapeutics Inc.

ATXS

Astria Therapeutics Inc.

HOLD

Current Price

$12.50

Market Cap

732.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCB
ATXS
Founded
1999
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
906.2M
732.4M
IPO Year
2017
2015

Fundamental Metrics

Financial Performance
Metric
MCB
ATXS
Price
$91.73
$12.50
Analyst Decision
Buy
Hold
Analyst Count
2
6
Target Price
$97.50
$24.33
AVG Volume (30 Days)
185.2K
793.4K
Earning Date
01-20-2026
03-10-2026
Dividend Yield
0.87%
N/A
EPS Growth
11.64
N/A
EPS
6.62
N/A
Revenue
$277,514,000.00
$706,000.00
Revenue This Year
$29.07
N/A
Revenue Next Year
$7.96
N/A
P/E Ratio
$13.90
N/A
Revenue Growth
2.53
N/A
52 Week Low
$47.08
$3.56
52 Week High
$96.75
$13.29

Technical Indicators

Market Signals
Indicator
MCB
ATXS
Relative Strength Index (RSI) 65.29 46.10
Support Level $87.74 $12.24
Resistance Level $96.75 $12.86
Average True Range (ATR) 3.62 0.25
MACD 0.70 -0.06
Stochastic Oscillator 74.08 32.54

Price Performance

Historical Comparison
MCB
ATXS

About MCB Metropolitan Bank Holding Corp.

Metropolitan Bank Holding Corp is a bank holding company. It provides a broad range of business, commercial, and retail banking products and services to small businesses, middle-market enterprises, public entities, and individuals in the New York metropolitan area. The services provided by the company include deposits, trade finance, cash management solutions, savings, electronic banking, cards, and others. The company also provides various lending products such as acquisition loans, construction loans, and lines of credit, for retail, office, hospitality, multifamily, mixed-use, warehouse and distribution, and specialty-use properties. The bank derives its revenue in the form of interest income on loans.

About ATXS Astria Therapeutics Inc.

Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.

Share on Social Networks: